Neurotrack Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $205K

  • Investors
  • 23

Neurotrack General Information

Description

Developer of digital cognitive assessment platforms designed to facilitate early detection and monitoring of Alzheimer's disease and other dementias. The company offers a platform that features rapid, patient-guided screening tests using eye-tracking technology and culturally-agnostic symbols, remote and in-clinic administration, instant and objective scoring integrated with electronic health records, ongoing monitoring tools, and educational resources targeting modifiable risk factors, enabling businesses, researchers, and health organizations to manage their brain health and reduce the risk of decline in the future.

Contact Information

Website
www.neurotrack.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 303 Twin Dolphin Drive
  • Suite 600
  • Redwood City, CA 94065
  • United States
+1 (650)
Primary Industry
Decision/Risk Analysis
Other Industries
Automation/Workflow Software
Medical Records Systems
Outcome Management (Healthcare)
Vertical(s)
Digital Health, SaaS, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 303 Twin Dolphin Drive
  • Suite 600
  • Redwood City, CA 94065
  • United States
+1 (650)

Neurotrack Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurotrack Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Accelerator/Incubator 01-Jan-2024 $205K Completed Generating Revenue
19. Accelerator/Incubator 24-Apr-2023 Completed Generating Revenue
18. Accelerator/Incubator 07-Feb-2023 Completed Generating Revenue
17. Later Stage VC 01-Nov-2022 Completed Generating Revenue
16. Secondary Transaction - Private 05-May-2022 Completed Generating Revenue
15. Accelerator/Incubator 22-Mar-2022 Completed Generating Revenue
14. Later Stage VC (Series D) 11-Mar-2022 Completed Generating Revenue
13. Debt - PPP 25-Jan-2021 Completed Generating Revenue
12. Later Stage VC (Series C) 11-Jun-2019 $21M $47.6M Completed Generating Revenue
11. Grant 17-Apr-2019 $3.3M $26.6M Completed Generating Revenue
To view Neurotrack’s complete valuation and funding history, request access »

Neurotrack Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D-1
Series D
Series C
Series B
Series A1 1,236,034 $0.000100 8% $8.25 $8.25 1x $8.25 9.21%
Series A 347,267 $0.000100 8% $6.09 $6.09 1x $6.09 2.59%
To view Neurotrack’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Neurotrack Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of digital cognitive assessment platforms designed to facilitate early detection and monitoring of Alzheimer's
Decision/Risk Analysis
Redwood City, CA
44 As of 2026

Berlin, Germany
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurotrack Competitors (15)

One of Neurotrack’s 15 competitors is NeuroNation MED, a Formerly VC-backed company based in Berlin, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroNation MED Formerly VC-backed Berlin, Germany
HeadCheck Health Venture Capital-Backed Vancouver, Canada
Savonix Formerly VC-backed San Francisco, CA
BrainCheck Venture Capital-Backed Austin, TX
Twill (Other Healthcare Technology Systems) Formerly VC-backed New York, NY
You’re viewing 5 of 15 competitors. Get the full list »

Neurotrack Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • Pending

  • Expiring in next 12 mo

Neurotrack Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10517520-B2 Method and system for correlating an image capturing device to a human user for analysis of cognitive performance Active 10-Nov-2016
US-10905366-B2 Method and system for correlating an image capturing device to a human user for analysis of cognitive performance Active 10-Nov-2016
US-11445955-B2 Method and system for correlating an image capturing device to a human user for analysis of cognitive performance Inactive 10-Nov-2016
US-20180125404-A1 Method and system for correlating an image capturing device to a human user for analysis of cognitive performance Active 10-Nov-2016
US-20200085361-A1 Method and system for correlating an image capturing device to a human user for analysis of cognitive performance Active 10-Nov-2016 A61B5/163
To view Neurotrack’s complete patent history, request access »

Neurotrack Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurotrack Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alzheimers Drug Discovery Foundation Not-For-Profit Venture Capital
AgeTech Collaborative from AARP Accelerator/Incubator
Alzheimer's Association Corporation
Matter (Consulting Services (B2B)) Accelerator/Incubator
Gershon Capital Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial

Neurotrack FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process